Initial chapters focus on agents that are considered standard care:

• 
  
• diuretics
  
• ACE inhibitors
  
• angiotensin receptor antagonists
  
• aldosterone antagonists
  
• beta-blockers

The discussion moves to agents currently under investigation:

• 
  
• Vasopressin antagonists
  
• erythropoietin

Next, the authors consider some controversial drugs:

• 
  
• inotropic agents
  
• antiarrhythmic drugs
  
• anticoagulants

An insightful examination of pharmacogenetics considers:

• 
  
• how studies of the genetic profile of patients helps determine which patient populations are most likely to respond to a given class of drugs
  
• the potential use of pharmacogenetics to tailor a pharmacologic regimen for maximum benefit and minimum risk

Multidrug pharmacy for heart failure therapy

An extremely helpful concluding chapter provides a roadmap of drugs with which to approach the patient with heart failure, along with an overview of the skills you need to use it most effectively. This straightforward, step-by-step algorithm will save you countless hours of research and help you make your prescribing decisions with confidence.